Pharma Journalist 8786 posts 0 comments

Braeburn announces the resubmission of the New Drug Application (NDA) for CAM2038, an investigational buprenorphine flexible-dose weekly and monthly depot injection for the treatment of…
Read More...

MIT researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. This…
Read More...

A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The Phase 1…
Read More...

Beactica announced that it has signed a three-year extension of its master services agreement with Sanofi. The agreement outlines the legal terms under which Beactica and Sanofi…
Read More...

Supported by Suzhou Government, MDS joins forces with major partners in various medical sectors and together stage the first Global Device Week in Suzhou from 6-9 September 2018 –…
Read More...

The U.S. Food and Drug Administration approved Palynziq (pegvaliase-pqpz) for adults with a rare and serious genetic disease known as phenylketonuria (PKU). Patients with PKU are born…
Read More...

Avara Pharmaceutical Services announced that it has agreed to acquire the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical…
Read More...

Samsung BioLogics announced that a third monoclonal antibody Drug Substance has been licensed by the US FDA (Food and Drug Administration) for its second plant, the world's largest…
Read More...

SMi Reports: With 2 weeks until the 2nd Annual Pharmaceutical Microbiology West Coast conference, potential attendees are urged to book their place soon, as places are limited. There…
Read More...

Clinigen Group plc has signed an agreement with Nordic Pharma Ltd. to manage the supply and distribution of aprotinin in a range of countries in Asia Pacific and South Africa.…
Read More...